Enliven Therapeutics
ELVN
ELVN
40 hedge funds and large institutions have $92.6M invested in Enliven Therapeutics in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 3 closing their positions.
Holders
40
Holders Change
+7
Holders Change %
+21.21%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
13
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$2.72M |
| 2 |
2
Two Sigma Investments
New York
|
$430K |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$396K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$1.94M |
| 5 |
5
Two Sigma Advisers
New York
|
$139K |
